Recent advances in the treatment of biofilms induced surgical site infections

Chopra, Hitesh; Islam, Md. Aminul; Sharun, Khan; Emran, Talha Bin; Al‐Tawfiq, Jaffar A.; Dhama, Kuldeep

doi:10.1097/js9.0000000000000036

Cited by 5 publications

(1 citation statement)

References 21 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical wound infections, which occur in the vicinity of a surgical incision within 30 or 90 days of surgery, are among the most prevalent hospital-acquired infections [71,72]. Endogenous pathogens are primarily responsible for the development of surgical wound infections, with S. aureus, particularly methicillin-resistant strains (MRSAs), being the predominant causative agent in recent years [11].…”

Section: Surgical Wound Infectionsmentioning

confidence: 99%

Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections

Wang,

Du,

Dong

et al. 2024

IJMS

View full text Add to dashboard Cite

Wound infection is one of the most important factors affecting wound healing, so its effective control is critical to promote the process of wound healing. However, with the increasing prevalence of multi-drug-resistant (MDR) bacterial strains, the prevention and treatment of wound infections are now more challenging, imposing heavy medical and financial burdens on patients. Furthermore, the diminishing effectiveness of conventional antimicrobials and the declining research on new antibiotics necessitate the urgent exploration of alternative treatments for wound infections. Recently, phage therapy has been revitalized as a promising strategy to address the challenges posed by bacterial infections in the era of antibiotic resistance. The use of phage therapy in treating infectious diseases has demonstrated positive results. This review provides an overview of the mechanisms, characteristics, and delivery methods of phage therapy for combating pathogenic bacteria. Then, we focus on the clinical application of various phage therapies in managing refractory wound infections, such as diabetic foot infections, as well as traumatic, surgical, and burn wound infections. Additionally, an analysis of the potential obstacles and challenges of phage therapy in clinical practice is presented, along with corresponding strategies for addressing these issues. This review serves to enhance our understanding of phage therapy and provides innovative avenues for addressing refractory infections in wound healing.

show abstract

Section: Surgical Wound Infectionsmentioning

confidence: 99%